• PMC51 CONCEPT ELABORATION-AN ESSENTIAL STAGE IN THE TRANSLATION OF PRO MEASURES

    Nov 1, 2010, 00:00

  • PRS20 OUTCOMES ASSOCIATED WITH IATROGENIC PNEUMOTHORAX

    Nov 1, 2010, 00:00

  • PCV11 PLATELET FUNCTION TESTS ARE HIGHLY VARIABLE WHEN USED TO IDENTIFY PATIENTS RESISTANT TO CLOPIDOGREL

    Nov 1, 2010, 00:00

  • PCV5 ASSESSMENT OF LIPID ABNORMALITIES- PREVALENCE AND ATTAINMENT OF LIPID GOALS/NORMAL LEVELS AMONG ADULTS IN THAILAND

    Nov 1, 2010, 00:00

  • ME1 METHODOLOGICAL ISSUES IN THE DEVELOPMENT OF AN AUSTRALIAN ALGORITHM FOR THE EQ-5D

    Nov 1, 2010, 00:00

  • PCN110 RESOURCE UTILIZATION AND DIAGNOSTIC APPROACHES IN NON-SMALL-CELL LUNG CANCER (NSCLC) ACROSS EUROPE- EPICLIN-LUNG STUDY

    Nov 1, 2010, 00:00

  • PCV22 THE INFLUENCE OF METEOROLOGICAL FACTORS ON CEREBRAL INFARCTION, INTRACEREBRAL HEMORRHAGE, SUBARACHNOID HEMORRHAGE AND TRANSIENT ISCHEMIC ATTACK

    Nov 1, 2010, 00:00

  • PDB27 A REVIEW OF HEALTH TECHNOLOGY ASSESSMENTS OF DIABETES IN ASIA AND OCEANIA

    Nov 1, 2010, 00:00

  • PCV119 SURVEY AT RETAIL PHARMACIES LEVEL ASSESSING QUALITY OF LIFE OF VKAS PATIENTS

    Nov 1, 2010, 00:00

  • PHP18 SCIENTIFIC EVIDENCE FOR THE RELATIONSHIP BETWEEN PHARMACEUTICAL BUDGET OF HEALTH INSURANCE FUND AND THE POLITICAL ELECTION CIRCLES IN HUNGARY

    Nov 1, 2010, 00:00

  • PUK27 TIME SAVINGS WITH Q4W (ONCE-MONTHLY) C.E.R.A.- A TIME AND MOTION STUDY CONDUCTED IN HEMODIALYSIS CENTRES IN FIVE EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PCV92 THE HEALTH AND ECONOMIC IMPACT OF SWITCHING FROM ATORVASTATIN TO GENERIC SIMVASTATIN IN BELGIUM

    Nov 1, 2010, 00:00

  • PMH30 ECONOMIC EVALUATION OF AGOMELATINE IN MAJOR DEPRESSIVE DISORDERS IN IRELAND

    Nov 1, 2010, 00:00

  • PND19 A LONG-TERM COST-EFFECTIVENESS MARKOV MODEL COMPARING DISEASE MODIFYING TREATMENTS IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS IN GERMANY

    Nov 1, 2010, 00:00

  • PDB44 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS SULFONYLUREA (SU) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN GERMANY

    Nov 1, 2010, 00:00

  • PSS33 REAL-LIFE DOSING OF BIOLOGICS IN PLAQUE PSORIASIS-A GERMAN SURVEY

    Nov 1, 2010, 00:00

  • PMH57 REVIEW OF CO-MORBIDITY OF EATING AND BODY DYSMORPHIC DISORDERS

    Nov 1, 2010, 00:00

  • PMS9 HEALTH-RELATED QUALITY OF LIFE IN INDIAN PATIENTS WITH RHEUMATOID ARTHRITIS

    Nov 1, 2010, 00:00

  • PMH14 ADHERENCE AND PERSISTENCE WITH DULOXETINE VERSUS ESCITALOPRAM AMONG HIGH HEALTH-CARE RESOURCES UTILIZERS WITH MAJOR DEPRESSIVE DISORDER

    Nov 1, 2010, 00:00

  • PCN93 COST-MINIMIZATION ANALYSIS OF XELOX (CAPECITABINE OXALIPLATIN) AS ADJUVANT TREATMENT IN STAGE III COLON CANCER UNDER THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

    Nov 1, 2010, 00:00

  • PR3 THE IMPACT OF FINNISH PHARMACEUTICAL PRICING SCHEME IN COST-EFFECTIVENESS ANALYSES

    Nov 1, 2010, 00:00

  • PCV14 ASPIRIN USE IS NOT ASSOCIATED WITH REDUCED MYOCARDIAL INFARCTION IN ELDERLY WITH TYPE 2 DIABETES WITH OR WITHOUT PRIOR HISTORY OF CARDIOVASCULAR DISEASE

    Nov 1, 2010, 00:00

  • PHP14 THE JOINT COMMITTEE FOR NEW DRUGS EVALUATION IN SPAIN- 6 YEARS OF EXPERIENCE

    Nov 1, 2010, 00:00

  • PMC33 ESTIMATING HEALTH STATE UTILITY VALUES FOR COMORBID HEALTH CONDITIONS

    Nov 1, 2010, 00:00

  • PHP36 THE AVAILABILITY AND FUNDING OF ORPHAN DRUGS IN BOSNIA AND HERZEGOVINA IN COMPARISON WITH NEIGHBORING COUNTRIES

    Nov 1, 2010, 00:00

  • PCV35 POTENTIAL DRUG-DRUG INTERACTIONS RELATED TO ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN TAIWAN

    Nov 1, 2010, 00:00

  • PCV57 COST ANALYSIS OF THE MEDICINE TREATMENT OF SOUTH AFRICAN PATIENTS WITH METABOLIC SYNDROME

    Nov 1, 2010, 00:00

  • PHP12 THE PUBLICS PREFERENCE ON THE PRIORITIES IN HEALTH CARE

    Nov 1, 2010, 00:00

  • PCV12 THE ECONOMIC BURDEN OF ATRIAL FIBRILLATION AND FLUTTER IN KOREA

    Nov 1, 2010, 00:00

  • PIH14 VALIDITY OF EQ-5D AND SF-12 AMONG MALAYSIAN

    Nov 1, 2010, 00:00

  • PHP35 THE IMPACT OF THE HOSPITAL FUNDING SYSTEM ON THE RANGE OF THE EXPENSIVE DRUGS AVAILABLE IN FRENCH AND ENGLISH HOSPITALS

    Nov 1, 2010, 00:00

  • PHP39 A COMPARISON OF GENERIC AND ORIGINATOR BRAND DRUG PRICES BETWEEN JORDAN AND THE UNITED KINGDOM

    Nov 1, 2010, 00:00

  • AD4 THE IMPACT OF PHARMACIST INTERVENTION ON PATIENTS ADHERENCE TO ANTIDEPRESSANT MEDICATION AND PATIENTREPORTED OUTCOMES

    Nov 1, 2010, 00:00

  • PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)

    Nov 1, 2010, 00:00

  • PCV81 THE COMPARATIVE ANALYSIS OF THE EFFECTIVENESS AND THE COSTS OF USING THE LOW-MOLECULAR-WEIGHT HEPARINS AND THE ORAL ANTICOAGULANTS FOR THE TREATMENT OF THE VENOUS THROMBOEMBOLISM IN POLAND

    Nov 1, 2010, 00:00

  • PRS15 THE POTENTIAL COST IMPACT OF USING A PEG HYDROGEL SEALANT TO PREVENT AIR LEAKS AFTER LUNG RESECTION SURGERY IN ITALY

    Nov 1, 2010, 00:00

  • PSS38 USE OF CALL CENTRE METHODOLOGY TO COLLECT QUALITY OF LIFE (QOL) DATA IN A CLINICAL TRIAL- A CASE STUDY OF PATIENTS WITH DIABETIC MACULAR EDEMA (DME)

    Nov 1, 2010, 00:00

  • PDB64 TREATMENT PERSISTENCE AMONG PATIENTS INITIATING INSULIN THERAPY WITH INSULIN DETEMIR IN A FLEXPEN VERSUS NPH INSULIN IN A VIAL. RETROSPECTIVE DATABASE ANALYSIS BASED ON A LARGE US MANAGED CARE ORGANIZATION

    Nov 1, 2010, 00:00

  • PIN48 PHARMACO-ECONOMICS OF ANTIBIOTICS

    Nov 1, 2010, 00:00

  • PGI18 ECONOMICS OF A SYMPTOM BASED PATIENT MANAGEMENT APPROACH FOR GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD), USING GERDQ, COMPARED TO AN INVASIVE APPROACH USING GASTROSCOPY AND PH-METRY

    Nov 1, 2010, 00:00

  • PHP113 LEVELS OF MEDICATION USE AMONG GERIATRIC PATIENTS IN ACUTE GERIATRIC CARE SETTINGS IN AUSTRIA

    Nov 1, 2010, 00:00

  • PUK4 A SYSTEMATIC REVIEW OF IMMUNOSUPPRESSIVE REGIMENS IN LOWER IMMUNOLOGICAL RISK RENAL TRANSPLANT RECIPIENTS

    Nov 1, 2010, 00:00

  • PMS52 PREFERENCES OVER BENEFITS AND RISKS ASSOCIATED WITH THE USE OF NSAIDS- EVIDENCE FROM PATIENTS DIAGNOSED WITH OSTEOARTHRITIS (OA) IN UK

    Nov 1, 2010, 00:00

  • PIN15 THE ECONOMIC BURDEN OF SURGICAL SITE INFECTION USING THERAPEUTIC ANTIBIOTIC UTILIZATION MEASURE-COMPARISON OF TWO TIME PERIODS

    Nov 1, 2010, 00:00

  • PCV16 INPATIENT MANAGEMENT AND COSTS OF ACUTE CORONARY SYNDROMES IN FACULTY HOSPITAL- COMPARISON OF STEMI AND NON-STEMI

    Nov 1, 2010, 00:00

  • PIN54 COST-EFFECTIVENESS ANALYSES (CEA) OF LOPINAVIR/RITONAVIR (LPV/R) AND ATAZANAVIR PLUS RITONAVIR (ATV VE HIV-1 INFECTED PATIENTS BASED ON CASTLE 48-WEEK STUDY- APPLICATION TO SWEDEN

    Nov 1, 2010, 00:00

  • PDB30 GLYCEMIC CONTROL IS WORSE AND COMPLICATIONS MORE PREVALENT IN TYPE 2 DIABETES PATIENTS WITH A HIGHER BMI IN CHINA

    Nov 1, 2010, 00:00

  • PCN27 THE COST OF CHEMOTHERAPY SIDE EFFECTS

    Nov 1, 2010, 00:00

  • PMH16 PHARMACIST-RUN METHADONE CLINIC IN A MALAYSIAN PUBLIC HEALTH CENTER- EVALUATING PATIENT SATISFACTION AND QUALITY OF LIFE OUTCOMES

    Nov 1, 2010, 00:00

  • PDB8 FACTORS ASSOCIATED WITH THE CHOICE OF FIRST INJETABLE THERAPY AND 6-MONTH TREATMENT OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES- DATA FROM THE CHOICE STUDY IN GERMANY

    Nov 1, 2010, 00:00

  • PMS46 DOSING PROFILE COMPARISON BETWEEN PATIENTS WITH FIBROMYALGIA INITIATING DULOXETINE AND PREGABALIN IN 2007- A LARGE NATIONAL RETROSPECTIVE COHORT STUDY

    Nov 1, 2010, 00:00

  • PHP59 EVOLUTION OF PUBLIC EXPENDITURE WITH PHARMACEUTICAL CARE IN BRAZIL DURING THE PERIOD 2005-2008

    Nov 1, 2010, 00:00

  • PCN4 LIKELIHOOD OF A SUBSEQUENT CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) EVENT IN PATIENTS RECEIVING MODERATELY OR HIGHLY EMETOGENIC CHEMOTHERAPY (MEC/HEC)

    Nov 1, 2010, 00:00

  • PIN46 KIOVIG FOR PRIMARY IMMUNODEFICIENCY- REDUCED INFUSION AND DECREASED COSTS PER INFUSION

    Nov 1, 2010, 00:00

  • PMS12 INCREASE OF INJECTION THERAPY ON PATIENTS WITH LOW BACK PAIN IN SOUTH KOREA (2006-2008)

    Nov 1, 2010, 00:00

  • PCV128 MODELING OF HEALTH SERVICE RESEARCH RESULTS WITH UPDATED COST DATA-THE GERSHWIN STUDY EXAMPLE

    Nov 1, 2010, 00:00

  • PGI1 A SYSTEMATIC REVIEW OF THE DIAGNOSTIC ACCURACY OF SEROLOGIC TESTS IN THE DIAGNOSIS OF CELIAC DISEASE

    Nov 1, 2010, 00:00

  • PMH42 UTILIZATION OF ANTIDEPRESSANTS IN SLOVAKIA

    Nov 1, 2010, 00:00

  • PIH7 BODY COMPOSITION CHANGES IN THE PREOPERATIVE PERIOD AND AFTER SURGERY

    Nov 1, 2010, 00:00

  • RS3 THE BAYESIAN APPROACH FOR PERFORMANCE-BASED PRICING-A CASE STUDY IN JAPAN

    Nov 1, 2010, 00:00

  • PRS36 ADHERENCE TO MEDICATION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH COPD- SGRQ-AN ALTERNATIVE METHOD TO IDENTIFY NONADHERENCE

    Nov 1, 2010, 00:00

  • PND14 SOCIO-ECONOMIC ASPECTS OF TESTING FOR NEUTRALIZING ANTIBODIES IN MS PATIENTS ON INTERFERON BETA TREATMENT IN AUSTRIA- A COST OF ILLNESS STUDY

    Nov 1, 2010, 00:00

  • PND2 WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE

    Nov 1, 2010, 00:00

  • PHP17 ACCESSIBILITY TO ORPHAN DRUGS IN JAPAN-HAS THE ORPHAN DESIGNATION SYSTEM CONTRIBUTED?

    Nov 1, 2010, 00:00

  • PMH54 USE OF THE ANALYTIC HIERARCHY PROCESS TO PRIORITIZE PATIENT-RELEVANT ENDPOINTS OF ANTIDEPRESSANT TREATMENT

    Nov 1, 2010, 00:00

  • PCV97 AN EVALUATION OF ONCE- VERSUS TWICE-DAILY DOSING ON PERSISTENCE WITH PRESCRIPTION MEDICATIONS IN CARDIOVASCULAR PATIENTS

    Nov 1, 2010, 00:00

  • PIN37 HEALTH ECONOMIC EVALUATION OF CONJUGATE PNEUMOCOCCAL VACCINES IN LATIN AMERICAN COUNTRIES

    Nov 1, 2010, 00:00

  • PSS1 META-ANALYSIS OF PARTIALLY HYDROLYZED 100-WHEY FORMULA VERSUS EXTENSIVELY HYDROLYZED FORMULAS IN THE PREVENTION OF ATOPIC DERMATITIS

    Nov 1, 2010, 00:00

  • PSY3 CLINICAL AND ECONOMIC OUTCOMES OF ZICONOTIDE NEUROMODULATION IN ITALIAN CANCER PATIENTS

    Nov 1, 2010, 00:00

  • PIH56 COMPARATIVE PRICING AND REIMBURSEMENT ANALYSIS BETWEEN BULGARIA AND THE CZECH REPUBLIC

    Nov 1, 2010, 00:00

  • PRS37 ASSOCIATION OF PATIENT-REPORTED INHALER SATISFACTION WITH PHYSICIAN-PERCEIVED COMPLIANCE WITH ASTHMA TREATMENT-RESULTS OF A CROSS-SECTIONAL STUDY IN FIVE EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PMS40 COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH GENERIC ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN

    Nov 1, 2010, 00:00

  • PMC23 PROPOSED METHODS FOR CONDUCTING SENSITIVITY ANALYSES ON THRESHOLD-DERIVED ESTIMATES OF VALUE-BASED PRICE AND PRODUCT PROFILES FOR EARLY-STAGE DRUGS

    Nov 1, 2010, 00:00

  • PHP26 DEVELOPMENT OF SYSTEMATIC PROCESS MAPS TO ENABLE COMPARISON BETWEEN DIFFERENT HTA AND DECISION MAKING SYSTEMS-THE FIRST STEP TO BENCHMARKING

    Nov 1, 2010, 00:00

  • PCN116 ANALYSIS OF THE EQ-5D QUESTIONNAIRE FOR PATIENTS WITH ADVANCED HER2-POSITIVE GASTRIC CANCER (HER2 AGC) BASED ON THE TRASTUZUMAB FOR GASTRIC CANCER (TOGA) STUDY

    Nov 1, 2010, 00:00

  • PDB92 CLINICAL AND ECONOMIC CONSEQUENCES OF THE PHARMACOLOGICAL HYPOGLYCEMIC TREATMENT OF TYPE 2 DIABETES IN CROATIA

    Nov 1, 2010, 00:00

  • PCN63 SURVEY AND ANALYSIS OF THE COSTS OF METASTATIC COLORECTAL CANCER TREATMENT IN SERBIA

    Nov 1, 2010, 00:00

  • PIH66 IDENTIFYING APPROPRIATE COMPARISON GROUPS IN GLOBAL PREGNANCY REGISTRIES

    Nov 1, 2010, 00:00

  • PDB86 HEALTH TECHNOLOGY ASSESSMENT OF DIABETES COMPOUNDS- THE POLISH PERSPECTIVE

    Nov 1, 2010, 00:00

  • PMC9 A NEO-RICARDIAN APPROACH TOWARD DISCOUNTING

    Nov 1, 2010, 00:00

  • DS3 A COMPARISON OF SIGNAL DETECTION PERFORMANCE BETWEEN REPORTING ODDS RATIO AND BAYESIAN CONFIDENCE PROPAGATION NEURAL NETWORK METHODS ON ADVERSE DRUG REACTION SPONTANEOUS REPORTING DATABASE OF THE THAI FDA

    Nov 1, 2010, 00:00

  • PCN64 SURVEY AND ANALYSIS OF THE COST OF METASTATIC COLORECTAL CANCER TREATMENT IN SLOVENIA

    Nov 1, 2010, 00:00

  • PCN22 ECONOMIC ANALYSIS OF CAPECITABINE PLUS OXALIPLATIN (XELOX) VERSUS FLUOROURACIL/LEUCOVORIN PLUS OXALIPLATIN (FOLFOX) IN THE TREATMENT OF ADVANCED GASTRIC CANCER IN CHINA

    Nov 1, 2010, 00:00

  • PIN18 A PILOT COST-OF-ILLNESS STUDY ON LONG TERM COMPLICATIONS/ SEQUELAE FOLLOWING ACUTE OTITIS MEDIA (AOM) IN BELGIUM

    Nov 1, 2010, 00:00

  • PCN46 ECONOMIC EVALUATION OF ONCOTYPE DX TO TARGET CHEMOTHERAPY USE IN LYMPH-NODE-NEGATIVE, OESTROGENRECEPTOR-POSITIVE, EARLY-STAGE BREAST CANCER IN IRELAND

    Nov 1, 2010, 00:00

  • PCN145 INEQUALITIES IN GEOGRAPHICAL ACCESS TO ONCOLOGY SERVICES IN GREECE AND THEIR IMPACT ON PATIENTS AND CARERS

    Nov 1, 2010, 00:00

  • PUK31 PSYCHOMETRIC VALIDATION OF THE SPANISH VERSION OF THE OVERACTIVE BLADDER QUESTIONNAIRE SHORT-FORM (OABQ-SF) TO ASSESS SEVERITY OF SYMPTOMS AND PATIENT HEALTH RELATED QUALITY OF LIFE IN SUBJECTS WITH OVERACTIVE BLADDER

    Nov 1, 2010, 00:00

  • PIH5 PHARMACOEPIDEMIOLOGICAL BURDEN OF PREGNANCY IN BELARUS

    Nov 1, 2010, 00:00

  • PHP124 DESCRIPTION OF THE PRICING AND REIMBURSEMENT SYSTEM IN THE CZECH REPUBLIC

    Nov 1, 2010, 00:00

  • PMC17 ASSISTANCE COST DEPENDING ON COMORBIDITY IN PRIMARY CARE A SPANISH INTERREGIONAL LEVEL

    Nov 1, 2010, 00:00

  • PCV12 COMPARATIVE EFFICACY OF EZETIMIBE-STATIN COMBINATION THERAPY AND STATIN MONOTHERAPY IN PATIENTS WITH HYPERCHOLESTEROLEMIA- SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMISED CONTROLLED TRIALS

    Nov 1, 2010, 00:00

  • PCV17 ESTIMATING COST OF INPATIENT CORONARY ANGIOGRAPHY USING STEP DOWN METHOD AT UNIVERSITY KEBANGSAAN MALAYSIA MEDICAL CENTER

    Nov 1, 2010, 00:00

  • PCN134 DEALING WITH CULTURALLY SENSITIVE QUESTIONS IN THE COURSE OF TRANSLATING EORTC QUALITY-OF-LIFE GROUP QUESTIONNAIRES

    Nov 1, 2010, 00:00

  • PCN39 COST UTILITY OF HUMAN PAPILOMA VIRUS VACCINE IN SPAIN

    Nov 1, 2010, 00:00

  • PHP82 ASSESSMENT OF PHARMACEUTICAL EXPENDITURE TRENDS IN PORTUGAL-PRICING AND REIMBURSEMENT POLICY

    Nov 1, 2010, 00:00

  • PCV15 META-REGRESSION APPROACH TO IDENTIFY THE EQUIVALENCE DOSE RATIOS OF ROSUVASTATIN TO SIMVASTATIN AND ATORVASTATIN

    Nov 1, 2010, 00:00

  • PDB8 COST-EFFECTIVENESS OF SWITCHING PATIENTS EITH TYPE 2 DIABETES FROM INSULIN GLARGINE TO INSULIN DETEMIR IN A CHINESE SETTING- A HEALTH ECONOMIC MODEL BASED ON THE PREDICTIVE STUDY

    Nov 1, 2010, 00:00

  • PIH38 EVALUATING THE HEALTH TECHNOLOGY ASSESSMENT PROGRAM IN THAILAND

    Nov 1, 2010, 00:00

  • PCV43 OFFSETTING ANNNUAL CARDIOVASCULAR DISEASE-RELATED MEDICAL AND PHARMACY COSTS BETWEEN PATIENTS CONTINUING STATIN MONOTHERAPY OR AUGMENTING STATIN MONOTHERAPY WITH NIACIN EXTENDED-RELEASE

    Nov 1, 2010, 00:00

  • PDB4 MEDICAL SERVICE COST ASSOCIATED WITH PIOGLITAZONE AND SULFONYLUREA TREATMENT AMONG TYPE 2 DIABETIC PATIENTS ENROLLED IN A US INTEGRATED HEALTH-CARE SYSTEM

    Nov 1, 2010, 00:00

  • PSS13 LINGUISTIC VALIDATION OF THE NATIONAL EYE INSTITUTE- QUALITY OF LIFE QUESTIONNAIRE-42 (NEI-RQL-42) FOR PATIENTS WITH REFRACTIVE ERROR MODIFIED FOR SIMPLIFIED CHINESE IN MAINLAND CHINA AND HINDI IN INDIA

    Nov 1, 2010, 00:00

  • PCV139 INTEGRATING PATIENT PREFERENCES IN EFFICIENCY FRONTIER ANALYSES USING THE ANALYTIC HIERARCHY PROCESS

    Nov 1, 2010, 00:00

  • PCV47 ASSOCIATION BETWEEN HOSPITAL PROCESS PERFORMANCE AND OUTCOME OF PATIENTS WITH ACUTE MYOCARIDAL INFARCTION

    Nov 1, 2010, 00:00

  • PRS25 A COST-UTILITY ANALYSIS FOR TIOTROPIUM BROMIDE IN THE LONG TERM TREATMENT OF SPECIFIC SUBGROUPS OF ITALIAN COPD PATIENTS

    Nov 1, 2010, 00:00

  • PR2 DECIDING ON VALUE FOR MONEY-A COMPARISON OF THE DUTCH, BELGIAN, SWEDISH, AND FRENCH DRUG REIMBURSEMENT SYSTEMS

    Nov 1, 2010, 00:00

  • PMS63 THE IMPACT OF THE DRUG CATEGORIZATION ON THE PRESCRIPTION AND CONSUMPTION OF NONSTEROIDAL ANTIINFLAMATORY DRUGS (NSAID)

    Nov 1, 2010, 00:00

  • PMS65 RETROSPECTIVE OBSERVATIONAL DATABASE ANALYSIS OF TNF- INHIBITOR SWITCHING PATTERNS IN PATIENTS IN THE UNITED STATES WITH RHEUMATOID ARTHRITIS IN TWO DISTINCT 'NATURALISTIC' TREATMENT SETTINGS USING A PRE-PROGRAMMED DATA ANALYSIS TOOL

    Nov 1, 2010, 00:00

  • PRS4 ASSESSMENT OF KNOWLEDGE ABOUT TUBERCULOSIS AMONG TB PATIENTS IN NORTH EAST LIBYA

    Nov 1, 2010, 00:00

  • PCN17 ECONOMIC EVALUATION OF PEMETREXED IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER IN JAPAN

    Nov 1, 2010, 00:00

  • PHP66 AN ASSESSMENT OF THE VARIATION IN ACCEPTED ICERS BY DISEASE TYPE- RESULTS FROM FOUR HTAS

    Nov 1, 2010, 00:00

  • PMS3 IMPROVEMENT IN EFFICACY AND SAFETY OUTCOMES AFTER CERVICAL ARTHROPLASTY VERSUS STANDARD ANTERIOR CERVICAL DISECTOMY AND FUSION (ACDF) SURGERIES-A META-ANALYSIS OF PUBLISHED RCTS

    Nov 1, 2010, 00:00

  • PSY2 POTENTIAL COST SAVINGS ASSOCIATED WITH FASTER BLEEDING RESOLUTION IN THE INPATIENT TREATMENT OF HEMOPHILIA WITH INHIBITORS

    Nov 1, 2010, 00:00

  • PCN161 DECISION-ANALYTIC MODELING IN CHRONIC MYELOID LEUKEMIA-A SYSTEMATIC OVERVIEW

    Nov 1, 2010, 00:00

  • PCN89 PROJECTING THE POTENTIAL COST-EFFECTIVENESS OF A BREAST CANCER VACCINE IN COMPARISON TO OTHER STANDARD TREATMENTS- A DECISION ANALYTIC MODEL

    Nov 1, 2010, 00:00

  • MT1 DOES MODEL CHOICE IN MIXED TREATMENT COMPARISONS AFFECT THE OUTCOME FOR DECISION-MAKERS?

    Nov 1, 2010, 00:00

  • PDB85 APPROVAL AFTER REJECTION-AN INSIGHT IN HTA RE-EVALUATIONS

    Nov 1, 2010, 00:00

  • PHP76 ALLOCATION OF A SINGLE BUDGET FOR HEALTH CARE, PROFESSIONAL EDUCATION, AND RESEARCH

    Nov 1, 2010, 00:00

  • PSY31 POSACONAZOLE VS. FLUCONAZOLE OR ITRACONAZOLE FOR THE PREVENTION OF FUNGAL INFECTIONS IN CANCER PATIENTS WITH PROLONGED NEUTROPENIA- A COST-EFFECTIVENESS ANALYSIS

    Nov 1, 2010, 00:00

  • PCV60 COST OF ANALYSIS OF THE ADVERSE EFFECTS OF THE ANTIARRYTHMIC DRUGS IN THE CLINCAL PRACTICE IN SPAIN

    Nov 1, 2010, 00:00

  • PDB95 SIMPLIFICATION OF PATIENT LEVEL SIMULATIONS TO COHORT MODEL FOR SCENARIO ANALYSIS

    Nov 1, 2010, 00:00

  • PGI4 PREVALENCE AND INCIDENCE OF HEPATITIS A IN A UNITED STATES MANAGED CARE CLAIMS DATABASE

    Nov 1, 2010, 00:00

  • PIH2 PEDIATRIC INTENSIVE CARE UNIT (PICU) ADMISSIONS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN THE ERA OF PALIVIZUMAB PROPHYLAXIS

    Nov 1, 2010, 00:00

  • PUK4 LONG-TERM HEALTHCARE RESOURCE CONSUMPTION AMONG HEMODIALYSIS PATIENTS AND PERITONEAL DIALYSIS PATIENTS IN TAIWAN

    Nov 1, 2010, 00:00

  • PMC22 REVENUE OPTIMIZATION MODEL TO OPTIMISE POSITION AND INDICATION OF NEW LAUNCHES

    Nov 1, 2010, 00:00

  • PMC8 BURDEN OF DISEASE AND ECONOMIC EVALUATION- ARE WE INVESTIGATING WHAT IT REALLY MATTERS?

    Nov 1, 2010, 00:00

  • PMH1 METABOLIC SYNDROME AND SECOND GENERATION ANTIPSYCHOTICS UTILIZATION-IMPACT OF PSYCHIATRIC COMORBIDITY AND POLYPHARMACY

    Nov 1, 2010, 00:00

  • PHP52 HIGH AND INTENSIVE UTILIZERS IN HEALTH CARE-A STRATEGIC CHALLENGE FOR MEDICAL SUPPLY IN THE COMPULSORY HEALTH INSURANCE

    Nov 1, 2010, 00:00

  • PRS39 QUALITY OF LIFE, PRODUCTIVITY LOSS, AND RESOURCE USE AMONG EMPLOYED ADULTS AGED 40 TO 64 YEARS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UNITED STATES (US) WORKFORCE

    Nov 1, 2010, 00:00

  • PMC4 COST ESTIMATION IN HEALTH ECONOMIC EVALUATIONS IN GERMANY- A SYSTEMATIC REVIEW

    Nov 1, 2010, 00:00

  • PND1 OUTCOME OF PHARMACIST INTERVENTION IN EDUCATION OF PATIENTS ON DUPLICATE PRESCRIPING HYPNOTIC-SEDATIVES

    Nov 1, 2010, 00:00

  • PDB24 DIRECT HEALTH CARE COSTS OF DIABETES MELLITUS IN HUNGARY

    Nov 1, 2010, 00:00

  • PHP11 NEW AND IMPROVED- DEFINING INNOVATION FOR HEALTH TECHNOLOGY POLICY

    Nov 1, 2010, 00:00

  • PIH21 IS ROUTINE IMMUNIZATION OF ELDERLY WITH THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE LIKELY TO BE CONSIDERED AS COST-EFFECTIVE?

    Nov 1, 2010, 00:00

  • PHP38 COMPLEXITY INCREASES UNCERTAINTY-THE IMPACT OF PBAC GUIDELINES (VERSION 4) ON PBAC DECISION-MAKING

    Nov 1, 2010, 00:00

  • PMC5 DEVELOPMENT OF A WEB-BASED SOFTWARE TOOL TO EVALUATE THE ECONOMIC IMPACT OF LOST PRODUCTIVITY DUE TO PREMATURE MORTALITY IN DEVELOPED AND EMERGING NATIONS

    Nov 1, 2010, 00:00

  • PCN72 COST-EFFECTIVENESS OF LETROZOLE AND OF ANASTROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER USING UPDATED SURVIVAL DATA FROM THE BIG 1-98 AND ATAC TRIALS-A UK PERSPECTIVE

    Nov 1, 2010, 00:00

  • PIH27 ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE (HRQOL) AMONG NON-PRESCRIPTION MEDICINE CUSTOMERS IN MALAYSIA

    Nov 1, 2010, 00:00

  • PIN42 THE COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) COMPARED WITH 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV10) IN TAIWAN

    Nov 1, 2010, 00:00

  • PSS2 USE OF INCREASED DOSAGES OF BIOLOGICS IN PLAQUE PSORIASIS AND POTENTIAL SAVINGS BY TREATING HIGH-DOSE PATIENTS WITH USTEKINUMAB INSTEAD-A BUDGET IMPACT MODEL

    Nov 1, 2010, 00:00

  • PHP65 VALUE BASED PRICING IN THE UK-A SURVEY-BASED APPROACH

    Nov 1, 2010, 00:00

  • PCV137 A SYSTEMATIC REVIEW ON DISEASE BURDEN AND UNMET NEEDS FOR VENOUS THROMBOEMBOLISM IN HOSPITALISED MEDICAL PATIENTS IN EUROPE SHOWS UNDER-UTILIZATION OF PREVENTIVE THERAPIES

    Nov 1, 2010, 00:00

  • PCN71 A COMPARISON OF THE COST-EFFECTIVENESS OF ZOLEDRONIC ACID FOR PREVENTING SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES FROM PROSTATE CANCER IN 4 EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PND43 IMPACT OF MEMANTINE TREATMENT INITIATION ON PSYCHOTROPICS USE- ANALYSES WITH THE RAMQ DATABASE

    Nov 1, 2010, 00:00

  • PDB12 TIME TO OPIOID USE AMONG COMMERCIALLY-INSURED PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN WHO INITIATED DULOXETINE VERSUS OTHER TREATMENTS-A PROPENSITY SCORE APPROACH

    Nov 1, 2010, 00:00

  • PHP49 INFLUENCE OF THE CHRONIC DISEASE IN HEALTH RESOURCES USE- ECONOMICS CONSECUENCES AND RISK STRATIFICATION

    Nov 1, 2010, 00:00

  • PCV131 AN INTERNATIONAL COMPARISON OF DUAL ANTIPLATELET USE BY STENT TYPE AT 6 MONTHS FOLLOWING HOSPITAL DISCHARGE AFTER ACUTE CORONARY SYNDROME- RESULTS FROM THE ANTIPLATELET TREATMENT OBSERVATIONAL REGISTRY II (APTOR-II)

    Nov 1, 2010, 00:00

  • PMS75 MODELING OF RHEUMATOID ARTHRITIS- A METHODOLOGICAL APPROACH

    Nov 1, 2010, 00:00

  • PND27 COST UTILITY ANALYSIS OF ORPHAN DRUGS- CASE STUDY OF DUODENAL LEVODOPA INFUSION VERSUS STANDARD TREATMENT IN PATIENTS WITH ADVANCED PARKINSONS DISEASE IN SWEDEN

    Nov 1, 2010, 00:00

  • PSY44 COST-EFFECTIVENESS OF A LIDOCAINE PLASTER RELATIVE TO GABAPENTIN AND PREGABALIN IN THE TREATMENT OF POSTHERPETIC NEURALGIA IN SPAIN

    Nov 1, 2010, 00:00

  • PDB62 COST-UTILITY ANALYSIS OF SAXAGLIPTIN AS AN ADD-ON THERAPY TO METFORMIN IN TYPE 2 DIABETES PATIENTS FROM THE BRAZILIAN PRIVATE HEALTH SYSTEM

    Nov 1, 2010, 00:00

  • PMS60 TNF THERAPY REDUCES THE ODDS OF WORSENING DISABILITY TRENDS IN RHEUMATOID ARTHRITIS OVER AT LEAST 2 YEARS-DATA FROM THE NDB-PORTUGAL COHORT

    Nov 1, 2010, 00:00

  • PCN28 UTILIZATION OF ANTIEMETIC PROPHYLAXIS ALONGSIDE CHEMOTHERAPY IN FOUR EUROPEAN COUNTRIES

    Nov 1, 2010, 00:00

  • PMH71 THE APPLICABILITY OF THE QALY AS EFFECT MEASURE IN CRIMINAL YOUTHS

    Nov 1, 2010, 00:00

  • BI4 ARE SECOND OPINIONS OBJECTIVE? BIASES IN SECOND-OPINION CONSULTATIONS

    Nov 1, 2010, 00:00

  • PIH54 METFORMIN FOR THE TREATMENT OF CHILDHOOD OBESITY- A SYSTEMATIC REVIEW AND META-ANALYSIS

    Nov 1, 2010, 00:00

  • PMH63 ANTIPSYCHOTIC PRESCRIBING TO THE ELDERLY-A TWO-YEAR COMPARATIVE ANALYSIS

    Nov 1, 2010, 00:00

  • PCN92 PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC EVALUATION OF OXALIPLATIN IN PALLIATIVE CHEMOTHERAPY OF METASTATIC COLORECTAL CANCER (MCCR)

    Nov 1, 2010, 00:00

  • PMS16 EARLY MORTALITY RATE OF BILATERAL HIP FRACTURES OVER 60 IN HUNGARY

    Nov 1, 2010, 00:00

  • PCV28 CARDIOVASCULAR RISK FACTORS AMONG ASIAN INDIAN AND WHITE ADULTS IN THE UNITED STATES

    Nov 1, 2010, 00:00

  • PCV33 THE IMPACT OF SWITCHING PATIENTS TO ROSUVASTATIN ON HEALTH-CARE EXPENDITURE AND PREVENTION OF CARDIOVASCULAR DISEASE- A COHORT STUDY

    Nov 1, 2010, 00:00

  • PND20 IS ROPINIROLE-PROLONGED RELEASE A COST-SAVING TREATMENT OPTION IN PARKINSONS DISEASE?

    Nov 1, 2010, 00:00

  • PRS24 LONG-TERM EFFECTIVENESS AND COST-EFFECTIVENESS OF SMOKING CESSATION INTERVENTIONS IN PATIENTS WITH COPD

    Nov 1, 2010, 00:00

  • PCV45 COST-EFFECTIVENESS ANALYSIS OF ROSUVASTATIN VERSUS ATORVASTATIN IN TURKEY- AN ANALYSIS BASED ON THE SYSTEMATIC REVIEW OF PUBLISHED RANDOMIZED CLINICAL TRIALS (RCTS)

    Nov 1, 2010, 00:00

  • PCN32 COMPARING FORECASTED WITH ACTUAL BUDGET IMPACT- REIMBURSED CANCER DRUGS IN THE NETHERLANDS

    Nov 1, 2010, 00:00

  • PIN26 ENVIRONMENTAL SITUATION OF DROP IN CENTERS FOR HIGH RISK POPULATION ON HIV/AIDS PREVENTION IN DHAKA, BANGLADESH

    Nov 1, 2010, 00:00

  • PDB18 THE PREVALENCE AND IMPACT OF BEING AT-RISK FOR DIABETES ACROSS US, JAPAN, AND EUROPE

    Nov 1, 2010, 00:00

  • PIN1 COST AND QUALITY OF LIFE ISSUES ASSOCIATED WITH PROTEASE INHIBITOR-BASED COMBINATION THERAPY TO TREAT HEPATITIS C

    Nov 1, 2010, 00:00

  • PMH55 THE SUBJECTIVE WELL-BEING UNDER NEUROLEPTIC SCALE SHORT FORM (SWN-K20) AND THE SF-36 AS QUALITY OF LIFE MEASURES IN SCHIZOPHRENIC PATIENTS

    Nov 1, 2010, 00:00

  • PCV2 SUCCESSFUL IMPLEMENTATION OF A PT APPROVED THERAPEUTIC INTERCHANGE PROGRAM OF ANGIOTENSIN II RECEPTOR BLOCKERS IN A MEDICAL CENTER IN TAIWAN

    Nov 1, 2010, 00:00

  • PCN79 ECONOMIC MODELING FOR TREATMENT FAILURE PATIENTS USING MULTIPLE ROUNDS OF THERAPY AS COMPARATOR

    Nov 1, 2010, 00:00

  • PMH43 HEALTH CARE UTILIZATION OF PATIENTS WITH DEPRESSION BEFORE AND AFTER INTIATING DULOXETINE

    Nov 1, 2010, 00:00

  • PSY24 COST OF CARE FOR CHRONIC MYELOID LEUKEMIA (CML) IN PATIENTS EXPERIENCING RESISTANCE AND/OR INTOLERANCE TO IMATINIB FROM THE PUBLIC HEALTH SYSTEM PERSPECTIVE IN MEXICO

    Nov 1, 2010, 00:00

  • PHP3 THE VALUE OF PATIENT PERSPECTIVES IN THE DRUG DEVELOPMENT LIFECYCLE

    Nov 1, 2010, 00:00

  • PIN43 A COST-EFFECTIVENESS ANALYSIS OF ANTIMICROBIAL THERAPY OF BLOODSTREAM INFECTIONS TREATMENT IN INTENSIVE CARE UNIT

    Nov 1, 2010, 00:00

  • PGI30 ASSESSMENT OF FEASIBILITY OF THE METHODOLOGICAL APPROACH DESCRIBED IN THE MODEL FOR THE REGULATION OF REIMBURSEMENT PRICES IN GERMANY

    Nov 1, 2010, 00:00

  • PCV32 BUDGET IMPACT ANALYSIS OF PACLITAXEL DRUG ELUTING STENT (DES) FOR THE TREATMENT OF LOWER LIMB PERIPHERAL ARTERIAL DISEASE (PAD) IN FRANCE

    Nov 1, 2010, 00:00

  • NI1 RETROSPECTIVE ANALYSIS OF TECHNOLOGY APPRAISALS CONDUCTED BY UKS NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) IN SEVERAL CANCER INDICATIONS- HIGHER EVIDENCE BARRIERS FOR TARGETED THERAPIES?

    Nov 1, 2010, 00:00

  • PND40 QUALITY OF LIFE OF CAREGIVERS IN HUNTINGTONS DISEASE-FIRST RESULTS FROM EURO-HDB STUDY

    Nov 1, 2010, 00:00

  • PND47 APPLICATION OF THE KANO METHODOLOGY FOR EVALUATING MIGRAINE TREATMENT EXPECTATIONS AMONG PATIENTS TREATED BY NEUROLOGISTS IN SPAIN-THE MIGREXX STUDY

    Nov 1, 2010, 00:00

  • PHP105 HOW CAN THE USE OF PREDICTIVE BIOMARKERS LEAD TO POSITIVE HTA RECOMMENDATIONS?

    Nov 1, 2010, 00:00

  • PIN68 EFFECT OF THE ANTIBIOTICS USE MONITORING PROGRAM FOR THE ACUTE UPPER-RESPIRATORY INFECTIONS DISEASE IN KOREAN CLINICS

    Nov 1, 2010, 00:00

  • PIN9 EFFICACY AND SAFETY OF RALTEGRAVIR IN TREATMENT NAIVE HIV PATIENTS-A MIXED TREATMENT COMPARISON APPROACH

    Nov 1, 2010, 00:00

  • PIH11 IDENTIFYING COST-EFFECTIVE TREATMENT WITH RALOXIFENE IN POSTMENOPAUSAL WOMEN USING RISK ALGORITHMS FOR FRACTURES AND INVASIVE BREAST CANCER

    Nov 1, 2010, 00:00

  • PCV121 A SURVEY OF PHYSICIANS ATTITUDES TOWARD THE CONTROL OF CARDIOVASCULAR RISK FACTORS. THE EURIKA STUDY.

    Nov 1, 2010, 00:00

  • PCN13 COST-BENEFIT ANALYSIS OF A 21-GENE RECURRENCE SCORE FOR EARLY STAGE BREAST CANCER IN SINGAPORE

    Nov 1, 2010, 00:00

  • PMH2 COMPARING ALL-CAUSE MEDICATION DISCONTINUATION WITH DEPOT AND ORAL ANTIPSYCHOTICS IN MATCHED COHORTS OF PATIENTS WITH SCHIZOPHRENIA- A 12-MONTH OBSERVATIONAL STUDY

    Nov 1, 2010, 00:00

  • PDB37 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS NPH INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN POLAND

    Nov 1, 2010, 00:00

  • DU1 THE IMPACTS OF ABUSE OF ANTIBIOTIC THERAPIES IN CHINA

    Nov 1, 2010, 00:00

  • PMS78 WORSE 6-MONTH BASELINE HAQ AND THE SELF-REPORTED RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX PREDICT IMPROVEMENT IN THEIR SCORES 6 MONTHS LATER, AMONG RHEUMATOID ARTHRITIS PATIENTS

    Nov 1, 2010, 00:00

  • CV4 THE CLINICAL EFFECTIVENESS OF 64-SLICE OR HIGHER COMPUTED TOMOGRAPHY ANGIOGRAPHY AS AN ALTERNATIVE TO INVASIVE CORONARY ANGIOGRAPHY IN THE INVESTIGATION OF SUSPECTED CORONARY ARTERY DISEASE

    Nov 1, 2010, 00:00

  • PHP47 EFFICIENCY IN DRUG PRESCRIPTION MEASURED BY THE APPLICATION OF ADJUSTED CLINICAL GROUPS IN THIRTEEN SPANISH PRIMARY CARE CENTRES

    Nov 1, 2010, 00:00

  • PRS8 A COMPARISON OF CLINICAL EFFICACY AND SAFETY OF CICLESONIDE WITH BUDESONIDE IN 1-1 AND 1-2 DOSE RATIOS IN THE TREATEMENT OF BRONCHIAL ASTHMA

    Nov 1, 2010, 00:00

  • PCN62 SURVEY AND ANALYSIS OF THE COSTS OF METASTATIC COLORECTAL CANCER TREATMENT IN SLOVAKIA

    Nov 1, 2010, 00:00

  • PIN24 IMPACT OF APPROPRIATE PRESCRIBING OF ANTIBIOTICS ON TREATMENT OUTCOMES, DAYS OF PATIENT HOSPITALIZATION AND COSTS OF ANTIBIOTIC TREATMENT IN HOSPITALS IN LESOTHO

    Nov 1, 2010, 00:00

  • PIH62 ESTIMATING THE CROSS-SECTIONAL NUMBER AND GESTATIONAL AGE DISTRIBUTION OF PREGNANT WOMEN FOR ECONOMIC ANALYSIS

    Nov 1, 2010, 00:00

  • PIN74 PARENTS DILEMMA WHETHER OR NOT TO VACCINATE THEIR CHILDREN AGAINST INFLUENZA A (H1N1)

    Nov 1, 2010, 00:00

  • PCV100 THE EFFECTS OF DOSING COMPLEXITY ON ADHERENCE WITH PRESCRIPTION MEDICATIONS COMMONLY USED FOR CARDIOVASCULAR PATIENTS

    Nov 1, 2010, 00:00

  • PIN15 COST-EFFECTIVENESS ANALYSIS OF 1-YEAR PEGINTERFERON ALFA-2A VERSUS 3 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA

    Nov 1, 2010, 00:00

  • PHP56 SERVICES FOR WHICH PHARMACISTS MAY LEVY A FEE- PHARMACIST INITIATED THERAPY (PIT)

    Nov 1, 2010, 00:00

  • PCV27 ADHERENCE TO ANTIHYPERTENSIVE MEDICATIONS- A QUALITATIVE STUDY AMONG OUTPATIENTS VISITING PUBLIC HOSPITALS IN THE CITY OF QUETTA, PAKISTAN

    Nov 1, 2010, 00:00

  • PSY6 COST-EFFECTIVENESS OF ORAL TRIPTAN THERAPY IN KOREA

    Nov 1, 2010, 00:00

  • PMC14 DISCOUNTING HEALTH EFFECTS- A REVIEW OF THE SYSTEM

    Nov 1, 2010, 00:00

  • PUK5 CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS IN RENAL REPLACEMENT THERAPY IN SO PAULO, BRAZIL

    Nov 1, 2010, 00:00

  • PDB17 EVALUATING THE CHOICE OF PEN VERSUS SYRINGE- IMPLICATIONS FOR LONG-TERM DIABETES MANAGEMENT

    Nov 1, 2010, 00:00

  • PSY9 THE ADMINISTRATION OF LIQUID INTRAVENOUS IMMUNOGLOBULINS IN SPAIN- A BUDGET IMPACT ANALYSIS TO ESTIMATE COSTS DUE TO AN INCREASING PRIVIGEN PENETRATION

    Nov 1, 2010, 00:00

  • PCN98 COST-EFFECTIVENESS OF A EUROPEAN COMMUNITY-BASED INTERVENTION- '10,000 STEPS GHENT'

    Nov 1, 2010, 00:00

  • PCV38 UTILIZATION, PRICE, AND EXPENDITURE TRENDS FOR ANGIOTENSIN RECEPTOR BLOCKERS IN THE MEDICAID PROGRAM

    Nov 1, 2010, 00:00

  • PSY10 A BUDGET IMPACT MODEL TO INVESTIGATE POTENTIAL COST SAVINGS ASSOCIATED WITH IMPROVEMENTS IN THE SAFETY PROFILE OF STRONG OPIOID ANALGESICS

    Nov 1, 2010, 00:00

  • PCV103 COST IMPLICATION OF UNACCEPTABLE REFILL-BASED ADHERENCE RATES OF ANTIHYPERTENSION TREATMENT IN THE SOUTH AFRICAN PRIVATE HEALTH CARE ENVIRONMENT

    Nov 1, 2010, 00:00

  • PMH70 TURKISH CULTURAL ADAPTATION AND VALIDATION OF THE ALCOHOL DEPENDENCE SCALE

    Nov 1, 2010, 00:00

  • PR1 THE APPLICATION OF PHARMACOECONOMIC MODELING TO ESTIMATE A VALUE-BASED PRICE FOR NEW CANCER DRUGS IN A PUBLICLY FUNDED HEALTH-CARE SYSTEM

    Nov 1, 2010, 00:00

  • BL1 COST-EFFECTIVENESS, VALUE OF INFORMATION, AND BUDGET IMPACT OF CERTOLIZUMAB PEGOL COMPARED TO SUBCUTANEOUS TUMOR NECROSIS FACTOR (TNF) INHIBITORS AND METHOTREXATE IN THE TREATMENT OF MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS IN FINLAND

    Nov 1, 2010, 00:00

  • PHP29 THE EFFECTS OF NICE APPRAISALS ON PRESCRIBING AND COSTSHARING BEHAVIOR IN THE US

    Nov 1, 2010, 00:00

  • PIN28 IMPACT OF METHODOLOGICAL CHOICES AND ASSUMPTIONS IN ECONOMIC EVALUATIONS OF ROTAVIRUS VACCINATION

    Nov 1, 2010, 00:00

  • PMH37 COST-EFFECTIVENESS OF ANTIPSYCHOTICS FOR THE TREATMENT OF RELAPSE PREVENTION FOR SCHIZOPHRENIA-THE SPANISH PERSPECTIVE

    Nov 1, 2010, 00:00

  • PIN27 AZITHROMYCIN OBSERVATIONAL STUDY IN BACTERIAL UPPER RESPIRATORY TRACT INFECTIONS IN INDIAN PATIENTS

    Nov 1, 2010, 00:00

  • PCV107 VALUATION OF HEALTH STATE UTILITIES RELATED TO CARDIOVASCULAR PREVENTION WITH ASPIRIN

    Nov 1, 2010, 00:00

  • PUK30 MAPPING THE OVERACTIVE BLADDER QUESTIONNAIRE-SHORT FORM (OABQ-SF) TO EQ-5D PATIENT PREFERENCES IN PATIENTS WITH OVERACTIVE BLADDER IN SPAIN

    Nov 1, 2010, 00:00

  • PCV98 IMPACT OF MEDICATION ADHERENCE ON HEALTH CARE EXPENDITURES BY MEDICARE BENEFICIARIES WITH HEART FAILURE

    Nov 1, 2010, 00:00

  • PUK18 COST-EFFECTIVENESS ANALYSIS OF TIMELY VERSUS LATE DIALYSIS REFERRAL AFTER RENAL TRANSPLANT FAILURE IN SPAIN

    Nov 1, 2010, 00:00

  • PHP26 VALIDATION OF ELECTRONIC DATABASE IN COMMUNITY HOSPITALS IN PATIENTS WITH ATRIAL FIBRILLATION

    Nov 1, 2010, 00:00

  • PCV129 TELEHEALTH-EARLY EVALUATION FINDINGS

    Nov 1, 2010, 00:00

  • ME4 DEVELOPMENT OF STANDARD COST LIST FOR ECONOMIC EVALUATION IN THAILAND

    Nov 1, 2010, 00:00

  • PIN45 COST-EFFECTIVENESS ANALYSIS OF TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B BOTH PLUS RIBAVIRIN IN SPAIN

    Nov 1, 2010, 00:00

  • PMC8 PREDICTING THE SF-6D PREFERENCE-BASED INDEX SCORE USING THE SF-8 HEALTH SURVEY

    Nov 1, 2010, 00:00

  • PIH52 EVALUATING THE PERCEPTION OF HOSPITAL PHARMACIST TOWARD THEIR CURRENT CLINICAL ROLE IN HEALTH CARE SYSTEM OF PAKISTAN

    Nov 1, 2010, 00:00

  • PSY40 COST-EFFECTIVENESS OF PREGABALIN VERSUS USUAL CARE IN REFRACTORY OUT-PATIENTS WITH NEUROPATIC PAIN FOLLOWED IN PRIMARY CARE SETTINGS

    Nov 1, 2010, 00:00

  • PMH33 ADJUNCTIVE ANTIPSYCHOTICS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN TURKEY-A HEALTH ECONOMIC PERSPECTIVE

    Nov 1, 2010, 00:00

  • PMS39 COST-EFFECTIVENESS OF RITUXIMAB VERSUS ALTERNATIVE ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY AFTER PREVIOUS FAILURE OF ONE ANTI-TNF AGENT FOR TREATMENT OF RHEUMATOID ARTHRITIS IN COSTA RICA

    Nov 1, 2010, 00:00

  • PCN24 EFFICACY OF ADJUVANT CHEMOTHERAPY WITH GEMCITABINE (GEM) COMPARED TO SURGERY-ONLY IN PATIENTS WITH RESECTED PANCREATIC CANCER- SYSTEMATIC REVIEW (SR) AND METAANALYSIS (MA)

    Nov 1, 2010, 00:00

  • PDB15 WEIGHT CHANGE FOR PATIENTS WITH TYPE 2 DIABETES- SECULAR TRENDS AND IMPACT OF DIFFERENT COMBINATIONS OF THERAPY

    Nov 1, 2010, 00:00

  • PCN101 COST-UTILITY ANALYSIS OF DASATINIB AS A SECOND-LINE TREATMENT IN THE CHRONIC PHASE OF CHRONIC MYELOID LEUKAEMIA IN RUSSIA

    Nov 1, 2010, 00:00

  • PMS54 GAP BETWEEN PATIENT-REPORTED ESTIMATION ON FRACTURE RISK AND THE WHO ASSESSMENT TOOL (FRAX) IN POSTMENOPAUSAL OSTEOPOROSIS

    Nov 1, 2010, 00:00

  • PCV41 COST COMPARISON STUDY IN ACUTE CORONARY SYNDROMES AND ACUTE HEART FAILURE PATIENTS

    Nov 1, 2010, 00:00

  • PHP6 RECOMMENDATIONS FOR A BIOLOGICS-SPECIFIC PRICING SYSTEM IN CHINA

    Nov 1, 2010, 00:00

  • PMC49 THE ROLE OF PATIENT-REPORTED OUTCOMES (PRO) AS PRIMARY ENDPOINTS IN THE EVALUATION OF MEDICINES APPROVED WITH PRO CLAIMS

    Nov 1, 2010, 00:00

  • PCN148 IMAGING TESTS IN STAGING AND SURVEILLANCE OF EARLY BREAST CANCER (EBC) IN ITALY-CHANGES IN ROUTINE CLINICAL PRACTICE AND COSTS IMPLICATIONS

    Nov 1, 2010, 00:00

  • PRS41 FACTORS AFFECTING QUALITY OF LIFE (QOL) OF ASTHMATIC PATIENTS IN SPAIN

    Nov 1, 2010, 00:00

  • PRS23 COMPARISON OF DIFFERENT METHODS FOR ASSESSING ATTRIBUTABLE COSTS-A CASE OF MEDICAL COSTS ATTRIBUTABLE TO OBESE IN PATIENTS WITH ASTHMA

    Nov 1, 2010, 00:00

  • PCV42 CLINICAL OUTCOMES FROM PHARMACIST-MANAGED ANTICOAGULATION CLINICS (ACC) IN PRIMARY CARE SETTINGS IN SINGAPORE

    Nov 1, 2010, 00:00

  • PDB39 EFFECT OF VARYING MODELLING ASSUMPTIONS ON THE COSTEFFECTIVENESS OF LIRAGLUTIDE 1.2 MG (AS A COMPONENT OF DUAL THERAPY) IN TYPE 2 DIABETES

    Nov 1, 2010, 00:00

  • PDB13 DIAPS 79, PRELIMINARY REPORT OF AN OBSERVATIONAL STUDY OF COSTS OF TYPE 2 DIABETES MELLITUS (T2DM) TREATMENT IN THE BRAZILIAN PRIVATE HEALTH-CARE SYSTEM (PHS)

    Nov 1, 2010, 00:00

  • PDB19 BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN FOR THE TREATMENT OF TYPE 2 DIABETES IN MEXICAN POPULATION AT PEMEX

    Nov 1, 2010, 00:00

  • IR3 THE USE OF IRT MODELING TO ACCOUNT FOR DIFFERENTIAL ITEM FUNCTIONING IN THE PROQOL-HIV QUESTIONNAIRE

    Nov 1, 2010, 00:00

  • PIH16 CONTENT AND PSYCHOMETRIC VALIDITY OF THE EYELASH SATISFACTION QUESTIONNAIRE (ESQ) IN CHINA

    Nov 1, 2010, 00:00

  • PGI31 EVALUATING THE POST OPERATIVE PRESCRIBING PRACTICES FOR APPENDICITIS IN PUBLIC HEALTH FACILITIES IN PAKISTAN

    Nov 1, 2010, 00:00

  • PMH50 TRENDS IN ANTIDEPRESSANT UTILIZATION, AND ASSOCIATED LABOR MARKET PARTICIPATION AND QUALITY OF LIFE OUTCOMES IN THE UNITED STATES- 2004-2007

    Nov 1, 2010, 00:00

  • PSS12 PSYCHOMETRIC EVALUATION OF MYOPIA-SPECIFIC INSTRUMENTS USED TO ASSESS HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS RECEIVING LASIK SURGERY

    Nov 1, 2010, 00:00

  • PCV78 COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN CHRONIC STABLE ANGINA PATIENTS IN AN AUSTRIAN SETTING

    Nov 1, 2010, 00:00

  • PMH41 COST-UTILITY ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN MAJOR DEPRESSIVE DISORDER IN ISRAEL

    Nov 1, 2010, 00:00

  • PHP88 STAKEHOLDER PERCEPTIONS OF CLINICAL DRUG TRIALS

    Nov 1, 2010, 00:00

  • PMH3 DETERMINANTS OF PSYCHIATRIC HOSPITAL ADMISSION IN SCHIZOPHRENIA

    Nov 1, 2010, 00:00

  • PSY67 PREDICTING EQ-5D UTILITIES FROM NEUROPATHIC PAIN SCORES- COMPARING INDIRECT MAPPING OF PREDICTED ITEM RESPONSES WITH DIRECT MAPPING OF SCORES

    Nov 1, 2010, 00:00

  • PRS4 EFFECTIVENESS OF VARENICLINE COMPARED TO BUPROPION AND NICOTINE REPLACEMENT THERAPY (NRT) FOR SMOKING CESSATION IN TWO SMOKING SPECIALIZED UNITS OF THE SPANISH PRIMARY CARE SETTING

    Nov 1, 2010, 00:00

  • PMH27 RECENT TRENDS IN PSYCHIATRIC PRESCRIPTION DRUG SPENDING

    Nov 1, 2010, 00:00

  • PGI32 USING DATA ENVELOPMENT ANALYSIS TO ESTABLISH THE EFFECTIVENESS EVALUATION OF DRUGS

    Nov 1, 2010, 00:00

  • PIN57 EVALUATION OF MEDICATION ADHERENCE IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY (ART) IN MAITAMA DISTRICT HOSPITAL, ABUJA NIGERIA

    Nov 1, 2010, 00:00

  • PND9 ASSESSMENT OF DISEASE BURDEN ASSOCIATED WITH EPILEPSY IN HUNGARY, BASED ON A CROSS-SECTIONAL QUESTIONNAIRE SURVEY OF 100 PATIENTS

    Nov 1, 2010, 00:00

  • PCV126 USE OF PROTON PUMP INHIBITORS (PPIS) IN ACUTE CORONARY SYNDROME PATIENTS TREATED WITH CLOPIDOGREL IN GERMANY, FRANCE, AND THE UNITED KINGDOM

    Nov 1, 2010, 00:00

  • HE1 A CROSS-COUNTRY COMPRASION OF HEALTH PERFORMANCE BETWEEN TAX-FUNDED AND SOCIAL HEALTH INSURANCE SYSTEM- THE CHANNEL VIA PREVENTIVE CARE

    Nov 1, 2010, 00:00

  • PUK26 THE INFLUENCE OF FUTURE UNRELATED COSTS ON COSTEFFECTIVENESS ESTIMATES-TREATMENT OF HYPERPHOSPHATEMIA WITH LANTHANUM CARBONATE IN PRE-DIALYIS PATIENTS WITH CHRONIC KIDNEY DISEASE

    Nov 1, 2010, 00:00

  • PCN22 EFFICACY AND CARDIAC SAFETY OF TRASTUZUMAB (T) IN THE ADJUVANT TREATMENT OF HER2-POSITIVE EARLY-STAGE BREAST CANCER- A SYSTEMATIC REVIEW (SR) AND META-ANALYSIS (MA)

    Nov 1, 2010, 00:00

  • PSY25 A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)

    Nov 1, 2010, 00:00

  • PCV9 RATE OF SUBSEQUENT CORONARY EVENTS AND DIRECT ECONOMIC OUTCOMES FOLLOWING AN ACUTE CORONARY EVENT BETWEEN PATIENTS AUGMENTING STATIN TO FURTHER REDUCE LDL-C VS. IMPROVING A COMPREHENSIVE LIPID PROFILE

    Nov 1, 2010, 00:00

  • PDB6 THE DISEASE BURDEN ANALYSIS OF 295 INPATIENTS WITH DIABETES MELLITUS FROM TONGJI HOSPITAL IN CHINA

    Nov 1, 2010, 00:00

  • PCV1 ESTIMATION OF STROKE-RELATED ADVERSE EVENTS, HEALTH CARE UTILITY AND COST OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

    Nov 1, 2010, 00:00

  • PCN82 RESEARCH PRIORITIZATION FOR PROSPECTIVE COMPARATIVE EFFECTIVENESS RESEARCH (CER) IN CANCER GENOMICS

    Nov 1, 2010, 00:00

  • PHP118 PERCEPTION OF PHARMACISTS SALES REPRESENTATIVES BY PHYSICIANS

    Nov 1, 2010, 00:00

  • PMH15 REAL-WORLD TREATMENT PATTERNS AND HEALTH CARE RESOURCE UTILIZATION IN GENERALISED ANXIETY DISORDER (GAD)- A RETROSPECTIVE UNITED STATES DATABASE ANALYSIS

    Nov 1, 2010, 00:00

  • PIH20 EXPLORATORY COST-EFFECTIVENESS ANALYSIS OF THE ANTERIOR REPAIR OF THE PELVIC ORGAN PROLAPSE COMPARING ANTERIOR COLPORRHAPHY (CONVETIONAL SURGERY) VERSUS PROLIFT MESH, UNDER THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

    Nov 1, 2010, 00:00

  • PHP22 UNIT COST OF BURMESE TRANSLATOR ACTIVITIES IN PHARMACY DEPARTMENT, SAMUTSAKHON HOSPITAL

    Nov 1, 2010, 00:00

  • PGI5 A BUDGET IMPACT ANALYSIS OF THE HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON IN BRAZIL

    Nov 1, 2010, 00:00

  • PCV51 THE IMPACT OF ACQUIRED BRAIN DAMAGE IN TERMS OF EPIDEMIOLOGY, ECONOMICS AND LOSS IN QUALITY OF LIFE

    Nov 1, 2010, 00:00

  • PND32 INFLUENCE OF AGE ON REFILL-ADHERENCE RATES OF ANTIEPILEPTIC DRUGS IN SOUTH AFRICA

    Nov 1, 2010, 00:00

  • PSY16 CHANGES IN SELF-REPORTED PAIN SCORES ASSOCIATED WITH DULOXETINE VERSUS OTHER ANTIDEPRESSANTS AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN THE UNITED STATES VETERANS AFFAIRS HEALTH CARE NETWORK

    Nov 1, 2010, 00:00

  • MA3 GLAUCOMA DISEASE PROGRESSION STATES- ESTABLISHING A DIRECT, QUANTITATIVE LINK BETWEEN VISUAL FIELD DEFECTS AND UTILITY LOSS

    Nov 1, 2010, 00:00

  • PMH11 COST-EFFECTIVENESS ANALYSIS FOR PHARMACOLOGICAL INTERVENTION AND COGNITIVE BEHAVIORAL TREATMENT (CBT) FOR MAJOR DEPRESSION IN THAILAND

    Nov 1, 2010, 00:00

  • PCN119 COMPARISON OF EQ-5D SCORE BETWEEN TREATMENT WITH 4 CYCLES OF ANTHRACYCLINE FOLLOWED BY 4 CYCLES OF TAXANE AND 8 CYCLES OF TAXANE FOR NODE POSITIVE BREAST CANCER PATIENTS AFTER SURGERY- N-SAS BC 02 TRIAL

    Nov 1, 2010, 00:00

  • PSS6 COST OF ILLNESS OF PSORIASIS-A 1-MONTH PROSPECTIVE STUDY IN SOUTHERN SWEDEN

    Nov 1, 2010, 00:00

  • PMH21 SOCIETAL COSTS OF BIPOLAR DISORDER-THE CASE OF SWEDEN

    Nov 1, 2010, 00:00

  • PIH49 PRESCRIBING PATTERNS OF SELECTIVE SEROTONIN RE-UPTAKE INHIBITORS AND SELECTIVE SEROTONIN AND NORADRENALINE RE-UPTAKE INHIBITORS IN CHILDREN AND ADOLESCENTS IN A SOUTH AFRICAN PRIVATE PRACTICE SETTING

    Nov 1, 2010, 00:00

  • CE2 COST-UTILITY ANALYSIS OF INTENSIVE LIFESTYLE INTERVENTIONS OR METFORMIN VERSUS STANDARD CARE IN THE PREVENTION OF TYPE 2 DIABETES IN HIGH-RISK SUBJECTS IN AN AUSTRALIAN SETTING. A SIMULATION ANALYSIS BASED ON THE LONG-TERM RESULTS OF TH ...

    Nov 1, 2010, 00:00

  • PIH20 HEALTH-RELATED QUALITY OF LIFE IN CHINESE CHRONIC PROSTATITIS PATIENTS

    Nov 1, 2010, 00:00

  • MT4 MIXED TREATMENT COMPARISON (MTC) OF ANTIFUNGAL DRUGS FOR PROPHYLAXIS TREATMENT AGAINST INVASIVE FUNGAL INFECTIONS (IFIS) IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL MALIGNANCIES OR ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANT ...

    Nov 1, 2010, 00:00

  • PSY8 ACCESS TO CARE AND HEALTH OUTCOMES AMONG THE SEVERE HEMOPHILIA A POPULATION IN CHINA TODAY

    Nov 1, 2010, 00:00

  • PRS8 THE EFFECT OF UNCONTROLLED ASTHMA ON HEALTH-RELATED QUALITY OF LIFE AND RESOURCE USE IN JAPAN AND THE UNITED STATES

    Nov 1, 2010, 00:00

  • PCV45 MEDICAL MALPRACTICE AND LITIGATION-WHAT DOES THIS MEAN FOR THE COST-EFFECTIVENESS OF DIAGNOSING CHEST PAIN?

    Nov 1, 2010, 00:00

  • PHP85 ASSESSING PUBLIC ACCOUNTABILITY OF KOREAN DRUG REIMBURSEMENT DECISION PROCESS

    Nov 1, 2010, 00:00

  • PCV53 THE BURDEN OF ISCHEMIC HEART DISEASES AT A MAJOR CARDIAC CENTER IN RIYADH, SAUDI ARABIA

    Nov 1, 2010, 00:00

  • PMH22 HEALTH SCIENCE STUDENTS ATTITUDES TOWARD RESEARCH AND ITS IMPLICATIONS TO TEACHING

    Nov 1, 2010, 00:00

  • PIH32 EVALUATING THE PERCEPTION OF ACADEMIC PHARMACIST TOWARD THEIR ROLE IN HEALTH-CARE SYSTEM OF PAKISTAN

    Nov 1, 2010, 00:00

  • AD3 A CONCEPTUAL FRAMEWORK THAT CAPTURES THE MULTIDIMENSIONAL ASPECT OF ADHERENCE IN A HEALTHECONOMIC MODEL- AN APPLICATION IN CHRONIC NONMALIGNANT PAIN MANAGEMENT

    Nov 1, 2010, 00:00

  • PRS5 EVALUATING SAFETY OUTCOMES OF LONG-ACTING BETA AGONISTS (LABAS) IN PATIENTS WITH ASTHMA

    Nov 1, 2010, 00:00

  • PSY56 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)- UNDERSTANDING THE BURDEN

    Nov 1, 2010, 00:00

  • PHP19 ANALYSIS OF THE GREEK PHARMACEUTICAL MARKET-THE FRAMEWORK, THE FACTS AND THE TRENDS (1998-2008)

    Nov 1, 2010, 00:00

  • PRS2 CARESS-THE CANADIAN REGISTRY OF SYNAGIS (2006-2009)

    Nov 1, 2010, 00:00

  • PSS19 COST-EFFECTIVENESS OF AGE-RELATED MACULAR DEGENERATION- A MODEL

    Nov 1, 2010, 00:00

  • PCV49 THE EVALUATION OF CARE PATHWAYS AS A COMPLEX INTERVENTION- APPLICATION OF A METHODOLOGICAL FRAMEWORK

    Nov 1, 2010, 00:00

  • PCV11 EFFECTS OF MEDICATION SUPPLY ON HEALTH-CARE COSTS AND RE-HOSPITALIZATIONS IN PATIENTS WITH CHRONIC HEART FAILURE

    Nov 1, 2010, 00:00

  • IN4 HERPES ZOSTER-ASSOCIATED ILLNESSES, QUALITY OF LIFE AND HEALTH-CARE COSTS AMONG 180 THAI PATIENTS

    Nov 1, 2010, 00:00

  • PCV114 ABSENTEISM AND IMPAIRED QUALITY OF LIFE IN CHRONIC VENOUS DISEASE IN ROMANIA

    Nov 1, 2010, 00:00

  • PIH28 WHY DO PATIENTS NOT ADHERE TO PRESCRIBED MEDICATION REGIMES? RESULTS OF TWO GERMAN SURVEYS

    Nov 1, 2010, 00:00

  • PHP114 DERIVING DOCTORS PRESCRIBING PATTERNS FROM HEALTH CARE CLAIMS- AN INSTRUMENTAL VARIABLE ANALYSIS

    Nov 1, 2010, 00:00

  • PDB53 COST-EFFECTIVENESS OF PREGABALIN VERSUS USUAL CARE IN REFRACTORY OUT-PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY (PDPN) FOLLOWED IN PRIMARY CARE SETTINGS

    Nov 1, 2010, 00:00

  • PDB10 LOWER EXTREMITY AMPUTATION PREVENTION (LEAP) IN SINGAPORE- ECONOMIC ANALYSIS OF RESULTS

    Nov 1, 2010, 00:00

  • PMH22 RESULTS OF THE GERMAN IDA STUDY-ASSESSING THE FINANCIAL IMPACT OF INFORMAL CARE AMONGST COMMUNITY LIVING DEMENTIA PATIENTS

    Nov 1, 2010, 00:00

  • PMS41 THE IMPACT OF MEDICATION ADHERENCE ON THE COST OF OSTEOPOROSIS FRACTURES IN GERMANY- A MODELLING APPROACH

    Nov 1, 2010, 00:00

  • PCN164 THE ECONOMICS OF CHRONIC MYELOGENOUS LEUKEMIA- A COMPARISON OF MODELING APPROACHES

    Nov 1, 2010, 00:00

  • PHP1 A STUDY EVALUATING PATTERN OF NON-PRESCRIPTION PURCHASE BY CONSUMERS FROM COMMUNITY PHARMACIES IN MALAYSIA

    Nov 1, 2010, 00:00

  • PMC40 ITEM CALIBRATION OF A GENERIC ROLE FUNCTIONING ITEM BANK

    Nov 1, 2010, 00:00

  • PDB21 COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR

    Nov 1, 2010, 00:00

  • PCN80 COST-EFFECTIVENESS ANALYSIS OF OXLIPLATIN IN ADJUVANT THERAPY FOR STAGE 3 COLON CANCER PATIENTS IN JAPAN

    Nov 1, 2010, 00:00

  • PCN163 EXTENDING FIXED EFFECT MODELS TO CENSORED COST DATA

    Nov 1, 2010, 00:00

  • PRS7 A COMPARISON OF CLINICAL EFFICACY AND SAFETY OF CICLESONIDE WITH FLUTICASONE IN 1-1 AND 1-2 DOSE RATIOS IN THE TREATMENT OF BRONCHIAL ASTHMA

    Nov 1, 2010, 00:00

  • PIN6 COMPARISON OF SOCIO-DEMOGRAPHIC AND CLINICAL FACTORS OF PULMONARY AND EXTRA PLUMONARY TUBERCULOSIS IN YEMEN

    Nov 1, 2010, 00:00

  • PHP28 IMPACT OF SAFETY ISSUESS BUDGET

    Nov 1, 2010, 00:00

  • PHP27 USING COLLABORATIVE PROGRAM BETWEEN PHARMACISTS AND NURSES YO IMPROVE SPONTANEOUS ADVERSE DRUG REACTION REPORTING SYSTEM IN THAILAND

    Nov 1, 2010, 00:00

  • PIH1 CRITICAL APPRAISAL OF SYSTEMATIC REVIEWS ASSESSING SAFETY OUTCOMES OF SSRIS IN THE PERINATAL PERIOD

    Nov 1, 2010, 00:00

  • PSY49 PATIENTS PREFERENCES IN OVERWEIGHT AND OBESITY THERAPY WITH DISCRETE CHOICE EXPERIMENTS

    Nov 1, 2010, 00:00

  • BL3 A CONCEPTUAL MODEL FOR POMPE DISEASE-THE BACKBONE FOR AN ECONOMIC EVALUATION OF AN ORPHAN DRUG

    Nov 1, 2010, 00:00

  • PSY61 RISK OF SURGICAL PROCEDURES IN THE INFLAMMATORY BOWEL DISEASE. ADMINISTRATIVE DATABASES AS A RESOURCE OF KNOWLEDGE

    Nov 1, 2010, 00:00

  • PIN21 EMPIRIC ANTIBIOTIC PRRESCRIBING IN SUBJECTS WITH INFLUENZA IN A UNITED STATES COMMERCIALLY INSURED POPULATION

    Nov 1, 2010, 00:00

  • PHP102 A SURVEY OF HTA RESEARCH METHODS AND TRENDS IN EUROPE

    Nov 1, 2010, 00:00

  • PCV84 ECONOMIC EVALUATION OF IMPLANTABLE LOOP RECORDER IN THE DIAGNOSIS OF SYNCOPE, UPDATE FROM THE SPANISH NATIONAL HEALTH SYSTEM

    Nov 1, 2010, 00:00

  • PMS19 THE INTRODUCTION OF A GERMAN ARTHROPLASTY REGISTER- COST SAVINGS FOR THE HEALTH CARE SYSTEM

    Nov 1, 2010, 00:00

  • HE3 ANALYSIS OF AN AFFORDABLE PRICE FOR PERFORMANCE-BASED RISK SHARING SCHEME- OMALIZUMAB ADAPTATION IN KOREA

    Nov 1, 2010, 00:00

  • PIN3 PRESCRIBER INFLUENCE ON THE PREVALENCE OF POTENTIAL ANTIRETROVIRAL DRUG-DRUG INTERACTIONS ON PRESCRIPTIONS IN SOUTH AFRICA

    Nov 1, 2010, 00:00

  • PMH18 THE EFFECT OF DIAGNOSED, SELF-REPORTED, AND AT-RISK DEPRESSION ON HEALTH-RELATED QUALITY OF LIFE AND WORK PRODUCTIVITY IN JAPAN AND EUROPE

    Nov 1, 2010, 00:00

  • PCN7 ASSESSING INTERFERON-ALPHA MONOTHERAPY IN PATIENTS WITH ADVANCE OR METASTATIC RENAL CELL CARCINOMA

    Nov 1, 2010, 00:00

  • PCV120 COMBINED MEDICATION CHOICE AND PATIENT PERSISTENCE IN HYPERTENSION THERAPY- EVIDENCE OF REAL-LIFE EFFECTIVENESS

    Nov 1, 2010, 00:00

  • PHP101 EVALUATION OF ACCEPTANCE AND REJECTION RATES OF ORPHAN DRUGS ACROSS SIX HTA BODIES

    Nov 1, 2010, 00:00

  • PMC6 ASSESSING PRODUCTIVITY AND ACTIVITY IMPAIRMENT DUE TO ILLNESS IN POLAND

    Nov 1, 2010, 00:00

  • PCN28 TRANSLATION AND VALIDATION OF EORTC QLQ-C30 INTO INDONESIAN VERSION FOR CANCER PATIENTS IN INDONESIA

    Nov 1, 2010, 00:00

  • EQ2 TESTING THE PERFORMANCE OF THE NEWLY DEVELOPED VERSION OF THE EQ-5D WITH 5 LEVELS OF SEVERITY- APPLICATION ON A COHORT OF PATIENTS WITH CHRONIC HEPATIC DISEASES

    Nov 1, 2010, 00:00

  • PHP14 PHARMACEUTICAL PROCUREMENT AND SUPPLY CHAIN IN PUBLIC AND PRIVATE SECTOR IN DELHI, INDIA

    Nov 1, 2010, 00:00

  • PCN140 IMPROVING PATIENT ACCESS TO CANCER DRUGS IN INDIA- USING ECONOMIC MODELING TO ESTIMATE A DRUG COST BASED ON MEASURES OF SOCIETAL VALUE

    Nov 1, 2010, 00:00

  • PHP31 THE COMMERCIAL EFFECTS OF REFORMULATIONS OF EXISTING DRUGS

    Nov 1, 2010, 00:00

  • PDB29 STATUS AND TREATMENT OF TYPE 2 DIABETES IN CHINA

    Nov 1, 2010, 00:00

  • PMS70 THE MANAGEMENT OF OSTEOARTHRITIS- ECONOMY OF NSAIDS

    Nov 1, 2010, 00:00

  • PMS72 INTERACTIVE ELECTRONIC INTERFACES (IEI)- BRIDGING THE COMMUNICATION GAP BY TRANSLATING ECONOMIC ANALYSIS RESULTS TO DECISION-MAKERS EVERYDAY PRACTICE

    Nov 1, 2010, 00:00

  • PGI27 STRUCTURED MANAGEMENT STRATEGY BASED ON THE GERDQ QUESTIONNAIRE VERSUS USUAL PRIMARY CARE FOR GASTROESOPHAGEAL REFLUX DISEASE- META-ANALYSIS OF FIVE EUROPEAN CLUSTER RANDOMIZED TRIALS

    Nov 1, 2010, 00:00

  • PCV21 THE RELATIVE EFFECTIVENESS PROFILE OF DRONEDARONE USING THE NUMBER NEEDED TO TREAT (NNT) APPROACH

    Nov 1, 2010, 00:00

  • PCV108 METHODS FOR ESTIMATING HEALTH-STATE UTILITIES IN PULMONARY ARTERIAL HYPERTENSION

    Nov 1, 2010, 00:00

  • PND23 COST-EFFECTIVENESS EVALUATION OF LEVODOPA/CARBIDOPA/ ENTACAPONE IN TREATMENT OF PARKINSON DISEASE

    Nov 1, 2010, 00:00

  • PCV94 POTENTIAL COST-EFFECTIVENESS OF A BIOMARKER TEST TO STRATIFY PATIENTS INDICATED FOR A CORONARY STENT

    Nov 1, 2010, 00:00

  • PMH36 ECONOMIC EVALUATION ANALYSIS IN THE TREATMENT OF BIPOLAR DISORDER WITH ARIPIPRAZOLE AND OTHER ATYPICAL ANTIPSYCHOTIC DRUGS IN SPAIN

    Nov 1, 2010, 00:00

  • PUK33 TEST-RETEST RELIABILITY AND ACCLIMATION EFFECT OF PATIENT PERCEPTION OF INTENSITY OF URGENCY SCALE (PPIUS) FOR OVERACTIVE BLADDER

    Nov 1, 2010, 00:00

  • PCV4 CLINICAL AND COST OUTCOMES OF VENOUS THROMBOEMBOLISM IN PATIENTS WHO UNDERWENT MAJOR ORTHOPEDIC SURGERY

    Nov 1, 2010, 00:00

  • PMS44 IMPACT OF OBESITY IN WORKING ADULTS WITH ARTHRITIS IN TERMS OF MEDICAL AND PRDUCTIVITY COSTS

    Nov 1, 2010, 00:00

  • PHP131 THE USE OF ECONOMIC EVALUATION IN A MEDICAL DEVICE COMMISION OF AN ITALIAN TEACHING HOSPITAL

    Nov 1, 2010, 00:00

  • PSY62 HEALTH TECHNOLOGY ASSESSMENT FOR RARE DISEASES- A MARKOVIAN MODEL FOR FABRY DISEASE (FD) CONSIDERING ENZYME REPLACEMENT THERAPY(ERT)

    Nov 1, 2010, 00:00

  • PHP104 DESIGNING EUROPEAN GUIDELINES FOR HEALTH OUTCOMES AND COST-EFFECTIVENESS ASSESSMENTS-THE ECHOUTCOME EUROPEAN COMMISSION PROJECT

    Nov 1, 2010, 00:00

  • PIN64 HERPES ZOSTER AND POST-HERPETIC NEURALGIA- CONSIDERATIONS FOR A PROSPECTIVE, CROSS-SECTIONAL, PATIENT REPORTED OUTCOMES STUDY

    Nov 1, 2010, 00:00

  • PCN100 COST-EFFECTIVENESS OF GEFITINIB VERSUS DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) IN SWEDEN

    Nov 1, 2010, 00:00

  • PIH31 THE EFFECTIVENESS OF SOCIAL MARKETING INTERVENTIONS IN REDUCING ALCOHOL CONSUMPTION AMONG CONSTRUCTION WORKERS AND OTHER RESIDENTS IN A COMMUNITY IN BANGKOK, THAILAND

    Nov 1, 2010, 00:00

  • PSY12 REAL-LIFE BUDGET IMPACT (BI) OF PARENTERAL IRON TREATMENT OF IRON DEFICIENCY ANEMIA/SYNDROME (IDA/IDS) IN SWITZERLAND

    Nov 1, 2010, 00:00

  • PIN7 ANTIFUNGAL TREATMENT FOR INVASIVE CANDIDIASIS- SYSTEMATIC REVIEW AND META-ANALYSIS

    Nov 1, 2010, 00:00

  • PCN85 SORAFENIB AND SUNITINIB IN METASTATIC RENAL CELL CARCINOMA- COST-EFFECTIVENESS ANALYSIS IN REIMBURSEMENT PROCEEDINGS VS. DATA FROM CLINICAL PRACTICE

    Nov 1, 2010, 00:00

  • PRS35 ASSESSING THE COST-EFFECTIVENESS OF BECLOMETHASONE/ FORMOTEROL IN THE TREATMENT OF MODERATE TO SEVERE PERSISTENT ASTHMA IN SPAIN

    Nov 1, 2010, 00:00

  • PCV52 COST OF MANAGING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION TO MANAGED CARE

    Nov 1, 2010, 00:00

  • PIN79 IS IT POSSIBLE TO OBTAIN WILLINGNESS-TO-PAY ESTIMATES IN EUROPE? A VALIDITY TEST OF STATED PREFERENCES FOR HEPATITIS-B TREATMENTS

    Nov 1, 2010, 00:00

  • PCN56 CLINICO-ECONOMIC ANALYSIS OF TREATMENT OF CHILDREN WITH RHABDOMYOSARCOMAS ON PROTOCOLS CWS

    Nov 1, 2010, 00:00

  • PGI15 COST-EFFECTIVENESS OF SEROLOGIC TESTING FOR DIAGNOSING CELIAC DISEASE

    Nov 1, 2010, 00:00

  • PGI19 PRESCRIPTION RATES AND ADHERENCE TO PROTON PUMP INHIBITOR THERAPY AMONG PATIENTS WHO REQUIRE LOW-DOSE ACETYLSALICYLIC ACID FOR CARDIOVASCULAR PREVENTION

    Nov 1, 2010, 00:00

  • PMC55 SYSTEMATIC REVIEW OF METHODS FOR META-ANALYSIS AND INDIRECT COMPARISON USED IN EXISTING SYSTEMATIC REVIEWS AND HTA REPORTS-RESULTS FROM THE FIRST PART OF EBAYESMET PROJECT

    Nov 1, 2010, 00:00

  • PSY5 COST-EFFECTIVENESS OF DEFERASIROX VERSUS DEFEROXAMINE IN TRANSFUSION-DEPENDENT THALASSAEMIA PATIENTS IN HONG KONG-AN INITIAL ANALYSIS

    Nov 1, 2010, 00:00

  • PCN130 QUALITY OF LIFE, OUTCOMES, AND COSTS IN THE BELGIAN POPULATION RECEIVING 90Y-ZEVALIN FOR NON-HODGKIN LYMPHOMA- A STUDY FOR REIMBURSEMENT REVISION

    Nov 1, 2010, 00:00

  • PHP132 VALUE OF MULTI-CRITERIA DECISION ANALYSIS IN EARLY ASSESSMENT OF MEDICAL DIAGNOSTIC DEVICES

    Nov 1, 2010, 00:00

  • PCV8 EVALUATION OF CLINICAL AND DIRECT ECONOMIC OUTCOMES FOLLOWING AN ACUTE CORONARY EVENT AMONG PATIENTS WITH SUBOPTIMAL HDL-C OR TRIGLYCERIDES ADMINISTERED EITHER STATIN AND NIACIN EXTENDED-RELEASE OR STATIN MONOTHERAPY

    Nov 1, 2010, 00:00

  • PSY48 RESOURCE USE AND COSTS OF THE GASTRIC BYPASS SURGERY VERSUS CLINICAL TREATMENT FOR OBESE PATIENTS WITH COMORBIDITIES UNDER THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM

    Nov 1, 2010, 00:00

  • PIN17 IMPACT OF YELLOW FEVER OUTBREAKS IN BRAZIL, 2000-2009

    Nov 1, 2010, 00:00

  • PCN86 COST-EFFECTIVENESS ANALYSIS OF SPLANCHNIC NERVE BLOCKADE IN PATIENTS WITH CANCER AND VISCERAL PAIN IN THE UPPER ABDOMEN

    Nov 1, 2010, 00:00

  • PUK13 INCIDENCE AND COST OF HOSPITALIZATIONS FOR ACUTE URINARY RETENTION ATTRIBUTABLE TO BENIGN PROSTATE HYPERPLASIA IN FRANCE

    Nov 1, 2010, 00:00

  • PCV122 THE IMPACT OF A CLINICAL PHARMACIST INTERVENTION ON LIPID-LOWERING IN A PRIMARY CARE SETTING

    Nov 1, 2010, 00:00

  • PCV65 HEALTH ECONOMIC ASSESSMENT OF FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY AND CHRONIC HEART FAILURE IN THE FAIR-HF TRIAL

    Nov 1, 2010, 00:00

  • PCN162 EXTRAPOLATION IN TRIAL-BASED COST-EFFECTIVENESS MODELING- IN SEARCH OF A STANDARD

    Nov 1, 2010, 00:00

  • MO1 STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS MODELS OF TREATMENT FOR ALZHEIMERS DISEASE

    Nov 1, 2010, 00:00

  • IN3 ASSESSMENT OF KNOWLEDGE ABOUT TUBERCULOSIS AMONG LIBYAN POPULATION IN NORTH EAST LIBYA

    Nov 1, 2010, 00:00

  • EQ4 DESCRIBING AND COMPARING HEALTH-RELATED QUALITY OF LIFE DERIVED FROM EQ-5D AND SF-6D IN A SWEDISH GENERAL POPULATION

    Nov 1, 2010, 00:00

  • PCV44 ROLE OF COMMUNITY PHARMACISTS IN HEALTH-RELATED EDUCATION AND COUNSELLING-VIEWS FROM GENERAL PUBLIC IN THE STATE OF PENANG, MALAYSIA

    Nov 1, 2010, 00:00

  • PCV7 SPONTANEOUS REPORTING OF ADVERSE DRUG REACTIONS INVOLVING HOSPITALIZED CARDIAC PATIENTS

    Nov 1, 2010, 00:00

  • PIH16 SURGICAL REPAIR OF ANTERIOR VAGINAL WALL PROLAPSE USING PROLIFT AND COLPORRHAPHY. A COST-EFFECTIVENESS ANALYSIS FOR A THIRD LEVEL HOSPITAL IN MEXICO

    Nov 1, 2010, 00:00

  • PCV43 PHYSICIAN-LEVEL CLASS EFFECT ON 90-DAY BLOOD PRESSURE VALUES- A META-ANALYSIS OF MULTILEVEL OBSERVATIONAL STUDIES OF VALSARTAN ANTIHYPERTENSIVE EFFECTIVENESS

    Nov 1, 2010, 00:00

  • PHP63 THE ECONOMIC IMPACT OF THE INITIATION OF PRESCRIPTION CONTROL IN THE GREEK SOCIAL SECURITY FUNDS

    Nov 1, 2010, 00:00

  • PCN158 TREATMENT DECISION CHANGE WITH 21-GENE RECURRENCE SCORE IN PATIENTS WITH EARLY STAGE BREAST CANCER (ESBC)- A META-ANALYSIS

    Nov 1, 2010, 00:00

  • PCV104 IMPACT OF POLICY-DRIVEN STATIN SWITCH PROGRAMS ON ADHERENCE AND PERSISTENCE

    Nov 1, 2010, 00:00

  • PIN60 CLINICAL PROFILE AND ADHERENCE PATTERN OF ANTI-RETROVIRAL THERAPY OF PEOPLE LIVING WITH HIV/AIDS REGISTERED AT DISTRICT ANTI RETROVIRAL THERAPY CENTRE, UDUPI DISTRICT

    Nov 1, 2010, 00:00

  • PND29 COST-UTILITY ANALYSIS OF RIZATRIPTAN VERSUS (GENERIC) SUMATRIPTAN IN SWEDEN

    Nov 1, 2010, 00:00

  • PRS51 ADVANCED PATTERN RECOGNITION METHODS FOR PREDICTING TREATMENT RESPONSE IN PATIENTS SUFFERING FROM ALLERGIC RHINITIS

    Nov 1, 2010, 00:00

  • PIH36 PATIENT SATISFACTION WITH FOLLITROPIN ALFA PREFILLED PEN IN WOMEN UNDERGOING OVARIAN STIMULATION- ELABORATION AND VALIDATION OF VENUSF QUESTIONNAIRE

    Nov 1, 2010, 00:00

  • PHP122 COMPETITIVENESS OF HUNGARY IN INTERNATIONAL CLINICAL TRIALS

    Nov 1, 2010, 00:00

  • PSS26 REVIEW OF UTILITIES IN ATOPIC DERMATITIS

    Nov 1, 2010, 00:00

  • PCN94 CAPECITABINE OXALIPLATIN (FOLFOX4) IN THE ADJUVANT TREATMENT OF PATIENTS WITH COLON CANCER (ACC)- COMPARISON OF DIRECT MEDICAL AND SOCIETAL (INDIRECT) COSTS

    Nov 1, 2010, 00:00

  • PHP18 LIFETIME DISTRIBUTION OF MEDICAL COST IN KOREA

    Nov 1, 2010, 00:00

  • PCN65 COST-EFFECTIVENESS ANALYSIS OF A FOBT-BASED COLORECTAL CANCER SCREENING PROGRAMME

    Nov 1, 2010, 00:00

  • PND34 A PSYCHOMETRIC EVALUATION OF THE REVISED SCOPA DIARY CARD IN PARKINSONS DISEASE PATIENTS

    Nov 1, 2010, 00:00

  • PMH2 EARLY RESPONSE PREDICTS SUBSEQUENT RESPONSE TO OLANZAPINE LONG-ACTING INJECTIONS IN THE TREATMENT OF SCHIZOPHRENIA

    Nov 1, 2010, 00:00

  • PCN33 IMPACT BUDGETING IN CROATIA- FULVESTRANT EXAMPLE

    Nov 1, 2010, 00:00

  • PMH8 HEALTH-CARE UTILIZATION COSTS AMONG SCHIZOPHRENIA PATIENTS TREATED WITH OLANZAPINE OR RISPERIDONE IN JAPAN

    Nov 1, 2010, 00:00

  • PUK10 GENERIC AZATHIOPRIN FOR KYDNEY TRANSPLANT PATIENTS-ANALYSIS OF COST SAVINGS

    Nov 1, 2010, 00:00
  • «
  • 131
  • 132
  • 133
  • 134
  • 135 (current)
  • 136
  • 137
  • 138
  • 139
  • 140
  • »